Page 117 - Bank-Muamalat-Annual-Report-2021
P. 117

ANNUAL REPORT 2021  115
               SUSTAINABILITY STATEMENT  OUR GOVERNANCE  OUR NUMBERS  OTHER INFORMATION
















            ROSHIDAH ABDULLAH                                                     Age 55       Female       Malaysian
            Independent Non-Executive Director                                 • Independent Non-Executive Director
                                                                               • Appointed on 1 September 2021




            Roshidah Abdullah was appointed as an Independent Non-Executive Director
            of Bank Muamalat Malaysia Berhad on 1 September 2021. She is the Chairman
            of  the  Board  Audit  Committee  and  a  member  of  the  Board  Nomination  &
            Remuneration and Board Compliance Committees.
            Roshidah  has  more  than  25  years’  experience  in  financial  management,
            corporate strategy development, governance and risk management in various
            organisations across diverse industries – upstream oil and gas; pharmaceutical
            manufacturing  and  distribution;  construction  and  engineering  –  with
            operations in Malaysia and abroad (particularly Kazakhstan, Indonesia and the
            Middle East). Having worked for almost 20 years in public listed companies and
            large conglomerates in the capacity of Chief Financial Officer and equivalent,
            she  has  had  much  exposure  to  the  requirements  and  set  up  of  code  of
            corporate  governance  and  enterprise-wide  risk  management  framework  in
            her previous organisations.

            Roshidah started her career as an auditor with Deloitte and Touche ("Kassim
            Chan  &  Co")  in  1989.  She  left  the  firm  in  December  1992  to  join  Time
            Engineering Berhad as a Group Accountant.
            In  January  1995,  Roshidah  moved  to  Remedi  Pharmaceuticals  (M)  Sdn  Bhd
            ("Remedi") to head the Finance Department. Remedi was at that point just
            secured  a  15-year  concession  contract  to  manage  the  drug  procurement
            for  the  Ministry  of  Health  Malaysia.  She  was  also  directly  involved  in  the
            merger  and  acquisition  of  Remedi,  Raza  Manufacturing  Berhad  and  Strand
            Pharmaceuticals Sdn Bhd by Pharmaniaga Berhad ("Pharmaniaga") in 1998,
            and the subsequent public listing of Pharmaniaga on Bursa Securities in 1999.
            In January 2000, Roshidah was promoted as the General Manager Finance and
            later in April 2003, as the Chief Financial Officer for Pharmaniaga. She was also
            Pharmaniaga’s Chief Operating Officer from 2006 to March 2008.
            Roshidah then spent the next two years until early 2010 as Finance Director at
            UEM  Group  Berhad  and  UEM  Builders  Berhad  before  she  returned  to
            Pharmaniaga to assist the Company to, amongst others, finalise its negotiation
            for  renewal  of  the  concession  agreement  and  prepare  for  the  change  in
            controlling shareholders.

            After  leaving  Pharmaniaga  in  March  2011,  Roshidah  had  a  short  stint  as  a
            business consultant. Then from April 2013 to October 2016, she was the Chief
            Financial Officer with Sumatec Resources Berhad.
            Roshidah  obtained  a  Bachelors  of  Arts  degree  in  Accountancy  from  South
            Australian Institute of Technology, Australia (now known as University of South
            Australia) in 1988. She is also a chartered member of Malaysian Institute of
            Accountants and a certified member of Australian CPA since 1992.
   112   113   114   115   116   117   118   119   120   121   122